Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Inhibitors (4)

Isotope-Labeled Compounds Related Products (9979):

Cat. No.	Product Name	Effect	Purity	Chemical Structure

HY-76938AS1

Actarit-d₆ sodium
Actarit-d₆ sodium is deuterated labeled Actarit.

HY-W131352S

N-Hexacosane-d₅₄		99.5%
N-Hexacosane-d₅₄ is the deuterium labeled N-hexacosane.

HY-B0696S

Tiagabine-d₆
Tiagabine-d₆ (NO050328-d₆) is deuterium labeled Tiagabine. Tiagabine (NO050328) is a potent and selective GABA reuptake inhibitor, used as an anticonvulsant agent, with IC₅₀s of 67, 446 and 182 nM for [³H]GABA uptake in Synaptosomes, Neurons and Glia, respectively.

HY-100713S

Temocapril-d₅
Temocapril-d₅ is the deuterium labeled Temocapril. Temocapril is an angiotensin-converting enzyme (ACE) inhibitor. Temocapril hydrochloride can be used for the research of hypertension, congestive heart failure, acute myocardial infarction, insulin resistance, and renal diseases.

HY-B0512S

Sulfamerazine-d₄		99.00%
Sulfamerazine-d₄ is a deuterium labeled Sulfamerazine. Sulfamerazine, a sulfonamide antibacterial, inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA) for binding to dihydropteroate synthesizes.

HY-W023443S

2-Isopropyl-5-methylpyrazine-d₃
2-Isopropyl-5-methylpyrazine-d₃ is deuterated labeled 2-Isopropyl-5-methylpyrazine.

HY-15030S1

Naproxen-d₃
Naproxen-d₃ is the deuterium labeled Naproxen. Radioactive isotopes labeled compounds can be used in metabolic analysis, allowing the movement of individual atoms to be precisely tracked and quantified.

HY-106617AS

Etoperidone-d₈ hydrochloride
Etoperidone-d₈ (hydrochloride) is the deuterium labeled Etoperidone hydrochloride.

HY-W654258

6-Mercaptopurine-¹³C,¹⁵N₂ hydrochloride		99.85%
6-Mercaptopurine-¹³C,¹⁵N₂ (hydrochloride) is ¹³C and ¹⁵N labeled 3,7-Dihydro-6h-purine-6-thione hydrochloride.

HY-132442S

∆8,9-Dehydro Estrone-d₂
?8,9-Dehydro Estrone-d₂ is the deuterium labeled ?8,9-Dehydro Estrone.

HY-B0360S

Rebamipide-d₄		99.0%
Rebamipide-d₄ is deuterium labeled Rebamipide. Rebamipide is a mucoprotective agent. Rebamipide induces COX-2 expression, increases PGE2 levels, and enhances gastric mucosal defense in a COX-2-dependent manner.

HY-W714795

Fluorescent brightener 71-d₁₀ sodium
Fluorescent brightener 71-d10 (sodium) (Optical Brightener DMS-d10 (sodium)) is the deuterium labeled Fluorescent brightener 71-d10 (sodium) (HY-W714795).

HY-W715121S

2,3,7,8-Tetrabromo dibenzo-p-dioxin-¹³C₁₂
2,3,7,8-Tetrabromo dibenzo-p-dioxin-¹³C₁₂ is ¹³C labeled 2,3,7,8-Tetrabromodibenzo[b,E][1,4]dioxine.

HY-100807S1

Quinolinic acid-¹³C₇
Quinolinic acid-¹³C₇ is the ¹³C labeled Quinolinic acid (HY-100807). Quinolinic acid is an endogenous N-methyl-D-aspartate (NMDA) receptor agonist synthesized from L-tryptophan via the kynurenine pathway and thereby has the potential of mediating N-methyl-D-aspartate neuronal damage and dysfunction.

HY-16106S1

Talazoparib-d4
Talazoparib-d₄ (BMN-673-d₄) is deuterium labeled Talazoparib. Talazoparib (BMN-673) is a highly potent, orally active PARP1/2 inhibitor.Talazoparib inhibits PARP1 and PARP2 enzyme activity with K_is of 1.2 nM and 0.87 nM, respectively. Talazoparib has antitumor activity.

HY-W010450S5

Thymine-¹³C₅,¹⁵N,¹⁵N₂
Thymine-¹³C₅,¹⁵N₂ (5-Methyluacil-¹³C₅,¹⁵N₂) is ¹³C and ¹⁵N labeled Thymine. Thymine is one of the four nucleobases in the nucleic acid of DNA and can be a target for actions of 5-fluorouracil (5-FU) in cancer treatment, with a K_m of 2.3 μM.

HY-132362S

1-(6-Hydroxy-2-propylheptyl) hydrogen 1,2-benzenedicarboxylate-d₄
Monopropylheptylphthalate 6-hydroxy-d4 is the deuterium labeled Monopropylheptylphthalate 6-hydroxy.

HY-173101S

GHFP(Leu-¹³C₆,¹⁵N)AER TFA
GHFP(Leu-¹³C₆,¹⁵N)AER TFA is the ¹³C- and ¹⁵N-labeled GHFP(Leu)AER TFA.

HY-W012578S1

2-Isopropyl-3-methoxypyrazine-¹³C₃
2-Isopropyl-3-methoxypyrazine-¹³C₃ is ¹³C labeled 2-Isopropyl-3-methoxypyrazine.

HY-B0806AS

Proguanil-d₄ hydrochloride
Proguanil-d₄ (hydrochloride) is the deuterium labeled Proguanil hydrochloride. Proguanil hydrochloride, an antimalarial proagent, is metabolized to the active metabolite Cycloguanil (HY-12784). Proguanil hydrochloride is a dihydrofolate reductase (DHFR) inhibitor.

Name
Email *

	Sorry, but the email address you supplied was invalid.